Davis's Drug Guide
etranacogene dezaparvovec
General
Pronunciation:
e-tra-nak-oh-jeen dez-a-par-voe-vek
Trade Name(s)
- Hemgenix
Ther. Class.
temporary class
antihemophiliacsPharm. Class.
temporary class
gene therapyThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Etranacogene Dezaparvovec." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580185/all/etranacogene_dezaparvovec.
Vallerand AHA, Sanoski CAC. Etranacogene dezaparvovec. Davis's Drug Guide. F.A. Davis Company; 2026. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580185/all/etranacogene_dezaparvovec. Accessed August 5, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Etranacogene dezaparvovec. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580185/all/etranacogene_dezaparvovec
Vallerand AHA, Sanoski CAC. Etranacogene Dezaparvovec [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 05]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580185/all/etranacogene_dezaparvovec.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - etranacogene dezaparvovec
ID - 3580185
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/3580185/all/etranacogene_dezaparvovec
PB - F.A. Davis Company
ET - 20
DB - Medicine Central
DP - Unbound Medicine
ER -
